APA

Bodei L., Mueller-Brand J., Baum R. P., Pavel M. E., Hörsch D., O'Dorisio M. S., O'Dorisio T. M., O'Dorisiol T. M., Howe J. R., Cremonesi M., Kwekkeboom D. J. & Zaknun J. J. (20130925). The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. : European journal of nuclear medicine and molecular imaging.

Chicago

Bodei L, Mueller-Brand J, Baum R P, Pavel M E, Hörsch D, O'Dorisio M S, O'Dorisio T M, O'Dorisiol T M, Howe J R, Cremonesi M, Kwekkeboom D J and Zaknun John J. 20130925. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. : European journal of nuclear medicine and molecular imaging.

Harvard

Bodei L., Mueller-Brand J., Baum R. P., Pavel M. E., Hörsch D., O'Dorisio M. S., O'Dorisio T. M., O'Dorisiol T. M., Howe J. R., Cremonesi M., Kwekkeboom D. J. and Zaknun J. J. (20130925). The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. : European journal of nuclear medicine and molecular imaging.

MLA

Bodei L, Mueller-Brand J, Baum R P, Pavel M E, Hörsch D, O'Dorisio M S, O'Dorisio T M, O'Dorisiol T M, Howe J R, Cremonesi M, Kwekkeboom D J and Zaknun John J. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. : European journal of nuclear medicine and molecular imaging. 20130925.